NCT05391100 Screening of Patients With Rheumatoid Arthritis for Interstitial Lung Disease
| NCT ID | NCT05391100 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Polyclinic of the Hospitaller Brothers of St. John of God, Budapest |
| Condition | Rheumatoid Arthritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-02-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-02-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The quantitative and qualitative analysis of RA lung involvement in the Hungarian population
Eligibility Criteria
Inclusion Criteria: * diagnosis of RA Exclusion Criteria: * pregnancy, breastfeeding * previous diagnosis of ILD, lung cancer, registered lung infection in the last 2 months
Contact & Investigator
Judit Majnik, MD PhD
PRINCIPAL INVESTIGATOR
Frequently Asked Questions
Who can join the NCT05391100 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Rheumatoid Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05391100 currently recruiting?
Yes, NCT05391100 is actively recruiting participants. Contact the research team at kflinta@hotmail.com for enrollment information.
Where is the NCT05391100 trial being conducted?
This trial is being conducted at Budapest, Hungary, Budapest, Hungary, Budapest, Hungary.
Who is sponsoring the NCT05391100 clinical trial?
NCT05391100 is sponsored by Polyclinic of the Hospitaller Brothers of St. John of God, Budapest. The principal investigator is Judit Majnik, MD PhD. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.